Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Cancer

Correction: Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function

L. Dyck; H. Prendeville; M. Raverdeau; M. M. Wilk; R. M. Loftus; A. Douglas; J. McCormack; B. Moran; M. Wilkinson; E. L. Mills; M. Doughty; A. Fabre; H. Heneghan; C. LeRoux; A. Hogan; E. T. Chouchani; D. O'Shea; D. Brennan; L. Lynch Correction: Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function J Exp Med

Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent

J. A. Elliott; N. E. Donlon; P. Beddy; C. L. Donohoe; S. L. Doyle; S. King; N. Ravi; J. V. Reynolds Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent Dis Esophagus
Metabolic Syndrome

Obesity and increased risk of esophageal adenocarcinoma

J. A. Elliott; C. L. Donohoe; J. V. Reynolds Obesity and increased risk of esophageal adenocarcinoma Expert Rev Endocrinol Metab
GORD

Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma

S. L. Doyle; A. M. Mongan; C. L. Donohoe; G. P. Pidgeon; M. Sherlock; J. V. Reynolds; J. Lysaght Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma Dis Esophagus
Insulin Resistance & Diabetes Metabolic Syndrome

Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research

S. L. Doyle; A. M. Bennett; C. L. Donohoe; A. M. Mongan; J. M. Howard; F. E. Lithander; G. P. Pidgeon; J. V. Reynolds; J. Lysaght Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research Nutr Res

IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity

S. L. Doyle; C. L. Donohoe; S. P. Finn; J. M. Howard; F. E. Lithander; J. V. Reynolds; G. P. Pidgeon; J. Lysaght IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity Am J Gastroenterol

Visceral obesity, metabolic syndrome, insulin resistance and cancer

S. L. Doyle; C. L. Donohoe; J. Lysaght; J. V. Reynolds Visceral obesity, metabolic syndrome, insulin resistance and cancer Proc Nutr Soc
Insulin Resistance & Diabetes Metabolic Syndrome

The role of obesity in gastrointestinal cancer: evidence and opinion

C. L. Donohoe; N. J. O'Farrell; S. L. Doyle; J. V. Reynolds The role of obesity in gastrointestinal cancer: evidence and opinion Therap Adv Gastroenterol

Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer

F. Donohoe; M. Wilkinson; E. Baxter; D. J. Brennan Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer Int J Mol Sci
NAFLD

Cancer survivorship, excess body fatness and weight-loss intervention-where are we in 2020?

A. S. Anderson; R. M. Martin; A. G. Renehan; J. Cade; E. R. Copson; A. J. Cross; C. Grimmett; L. Keaver; A. King; E. Riboli; C. Shaw; J. M. Saxton Cancer survivorship, excess body fatness and weight-loss intervention-where are we in 2020? Br J Cancer

Older posts

Newer posts

← Previous Page1 … Page9 Page10 Page11 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI